| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
What is an ATC-Code? | ATC-Overview |
|
L | | IP | CI | | Methergin | 5 ampoule(s) | 3.03 | 7.55 | 10 % | | Injektionslösung s.c.: Methylergometrini Maleas | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
|
| | IP | | | Propess | 5 piece(s) | PR | PR | k.A. | | | Ferring AG | A | FB | | G |  |
| | IP | | | Prostin E2 3 mg | 4 Tablet(s) | PR | PR | k.A. | | Vaginaltablette: Dinoprostonum 3 mg | Pfizer AG | A | FB | | G |  |
|
| | IP | | | Nalador | 3 ampoule(s) | 153.94 | 193.10 | k.A. | | Lyophilisate: Sulprostonum | Bayer (Schweiz) AG | A | FB | | G |  |
| | IP | | | Nalador | 3 | PR | PR | k.A. | | Lyophilisate: Sulprostonum | Bayer (Schweiz) AG | A | FB | | G |  |
|
| | IP | CI | | Angusta 25 ug | 8 | PR | PR | k.A. | | Tablets: Misoprostolum | Norgine AG | B | FB | | G |  |
| | IP | CI | | MisoOne 400 mcg | Tablet(s) | 11.14 | 25.10 | k.A. | | Tablets: Misoprostolum 400 µg | Nordic Pharma GmbH | A | FB | | G |  |
|
L | | IP | CI | | Levosert | | 119.75 | 153.85 | 10 % | | Intrauterines Wirkstofffreisetzungssystem: Levonorgestrelum 52 mg | Gedeon Richter (Schweiz) AG | B / SL / LPPV | FB | | G |  |
L | | IP | CI | | Mirena | piece(s) | 149.08 | 187.55 | 10 % | | Intrauterines Wirkstofffreisetzungssystem: Levonorgestrelum 52 mg | Bayer (Schweiz) AG | B / SL | FB | | G |  |
| | IP | CI | | Kyleena 19.5 mg | | PR | PR | k.A. | | Gestagen abegebendes Intrauterinsystem: Levonorgestrelum 19.5 mg | Bayer (Schweiz) AG | B / LPPV | FB | | G |  |
| | IP | CI | | Jaydess 10 mcg/24 Stunden | piece(s) | PR | PR | k.A. | | Intrauterines Wirkstofffreisetzungssystem: Levonorgestrelum 13.5 mg | Bayer (Schweiz) AG | B / LPPV | FB | | G |  |
|
| | IP | | | MyLoop | | PR | PR | k.A. | | | Labatec Pharma SA | B | FB | | G |  |
| | IP | | | MyLoop | 3 | PR | PR | k.A. | | | Labatec Pharma SA | B | FB | | G |  |
| | IP | CI | CM | Circlet | | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Organon GmbH | B | FB | | G |  |
| | IP | CI | CM | Circlet | 3 | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Organon GmbH | B | FB | | G |  |
| | IP | CI | | Danisia 0.120mg/0.015mg | | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Sandoz Pharmaceuticals AG | B | FB | | G |  |
| | IP | CI | | Danisia 0.120mg/0.015mg | 3 | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Sandoz Pharmaceuticals AG | B / LPPV | FB | | G |  |
| | IP | CI | | FemiRing | | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | FemiRing | 3 | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | NuvaRing | Sachet(s) | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Organon GmbH | B / LPPV | FB | | G |  |
| | IP | CI | | NuvaRing | | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Organon GmbH | B / LPPV | FB | | G |  |
| | IP | CI | | NuvaRing | 3 Sachet(s) | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Organon GmbH | B / LPPV | FB | | G |  |
| | IP | CI | | NuvaRing | 3 | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Organon GmbH | B / LPPV | FB | | G |  |
| | IP | CI | | Ornibel | | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Xiromed SA | B | FB | | G |  |
| | IP | CI | | Ornibel | 3 | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Xiromed SA | B | FB | | G |  |
| | IP | CI | | Ornibel | 6 | PR | PR | k.A. | | Vaginal ring: 2 Active Agents | Xiromed SA | B | FB | | G |  |
|
| | IP | CI | | Parlodel | 30 Tablet(s) | 14.77 | 29.25 | 10 % | | Tablets: Bromocriptinum 2.5 mg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
| | IP | CI | | Parlodel | 100 Tablet(s) | 45.05 | 68.10 | 10 % | | Tablets: Bromocriptinum 2.5 mg | Novartis Pharma Schweiz AG | B / SL | FB | | G |  |
|
| | IP | CI | | Dostinex | 2 | 9.99 | 19.65 | 10 % | | Tablets: Cabergolinum | Pfizer AG | B / SL | FB | | G |  |
| | IP | CI | | Dostinex | 8 | 36.95 | 58.80 | 10 % | | Tablets: Cabergolinum | Pfizer AG | B / SL | FB | | G |  |
|
| | IP | CI | | Norprolac 75 ug | 30 Tablet(s) | 32.87 | 54.15 | 10 % | | Tablets: Quinagolidum 75 µg | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Norprolac 150 ug | 30 Tablet(s) | 58.63 | 83.70 | 10 % | | Tablets: Quinagolidum 150 µg | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Norprolac Starter-pack | Kombipackung(en) | 4.30 | 9.05 | 10 % | | ug +: Quinagolidum 25 µg ug +: Quinagolidum 50 µg | Ferring AG | B / SL | FB | | G |  |
| | IP | CI | | Norprolac 25 ug | Kombipackung(en) | PR | PR | k.A. | | Tablets: Quinagolidum 25 µg | Ferring AG | B | FB | | G |  |
| | IP | CI | | Norprolac 50 ug | Kombipackung(en) | PR | PR | k.A. | | Tablets: Quinagolidum 50 µg | Ferring AG | B | FB | | G |  |
|
| | IP | CI | | Hänseler Achillea | 30 | PR | PR | k.A. | | Coated tablets: Millefolii Herbae Extractum Aquosum Siccum 250 mg | Hänseler AG | D | FB | | G |  |
| | IP | CI | | Hänseler Achillea | 60 | PR | PR | k.A. | | Coated tablets: Millefolii Herbae Extractum Aquosum Siccum 250 mg | Hänseler AG | D | FB | | G |  |
| | IP | CI | | Hänseler Achillea | 90 | PR | PR | k.A. | | Coated tablets: Millefolii Herbae Extractum Aquosum Siccum 250 mg | Hänseler AG | D | FB | | G |  |
| | | CI | Ph | Menosan Salvia | 30 | PR | PR | k.A. | | Tablets: Extractum Spissum ex Salviae Officinalis Folii Recentis Tinctura (Salvia Officinalis l., Folium) 3400 mg | A.Vogel AG | D | FB | | G |  |
| | | CI | Ph | Menosan Salvia | 90 | PR | PR | k.A. | | Tablets: Extractum Spissum ex Salviae Officinalis Folii Recentis Tinctura (Salvia Officinalis l., Folium) 3400 mg | A.Vogel AG | D | FB | | G |  |
| | | | | Milupa Milactin Stilltee | 200 g | PR | PR | k.A. | | Granulate: 6 Active Agents | Nutricia Milupa SA | D | FB | | G |  |
|
| | IP | | | Atosiban KLASA 6.75 mg/ 0.9 ml | | PR | PR | k.A. | | Injection solution: Atosibanum 6.75mg / 0.9ml | Pharma Consulting Marion Senn AG | B | FB | | G |  |
| | IP | | | Tractocile 6.75 mg / 0.9 ml | Durchstechflasche(n) | PR | PR | k.A. | | Injection solution: Atosibanum 7.5mg / 1ml | Ferring AG | B | FB | | G |  |
| | IP | | | Tractocile 6.75 mg / 0.9 ml | Durchstechflasche(n) | PR | PR | k.A. | | Injection solution: Atosibanum 7.5mg / 1ml | Ferring AG | B | FB | | G |  |
| | IP | | | Atosiban KLASA 37.5 mg/ 5 ml | | PR | PR | k.A. | | Concentrate for infusion: Atosibanum 37.5mg / 5ml | Pharma Consulting Marion Senn AG | B | FB | | G |  |
|
| | | CI | PhCM | Oprane ‐ I | 30 Tablet(s) | 11.33 | 20.90 | 10 % | | Coated tablets: Agni Casti Fructus Extractum Siccum (Vitex Agnus-Castus l., Fructus) 20 mg | OM Pharma Suisse SA | D / SL | FB | | G |  |
| | | CI | PhCM | Oprane ‐ I | 3 x 30 Tablet(s) | 29.36 | 54.15 | 10 % | | Coated tablets: Agni Casti Fructus Extractum Siccum (Vitex Agnus-Castus l., Fructus) 20 mg | OM Pharma Suisse SA | D / SL | FB | | G |  |
| | | CI | PhCM | Premens ‐ I | 30 Tablet(s) | 11.33 | 20.90 | 10 % | | Coated tablets: Agni Casti Fructus Extractum Siccum (Vitex Agnus-Castus l., Fructus) 20 mg | Zeller Medical AG | D / SL | FB | | G |  |
| | | CI | PhCM | Premens | 3 x 30 Tablet(s) | 29.36 | 54.15 | 10 % | | Coated tablets: Agni Casti Fructus Extractum Siccum (Vitex Agnus-Castus l., Fructus) 20 mg | Zeller Medical AG | D / SL | FB | | G |  |
| | | CI | Ph | Prefemin | 30 Tablet(s) | PR | PR | k.A. | | Coated tablets: Agni Casti Fructus Extractum Siccum (Vitex Agnus-Castus l., Fructus) 20 mg | Max Zeller Söhne AG | D | FB | | G |  |
| | | CI | Ph | Prefemin | 3 x 30 Tablet(s) | PR | PR | k.A. | | Coated tablets: Agni Casti Fructus Extractum Siccum (Vitex Agnus-Castus l., Fructus) 20 mg | Max Zeller Söhne AG | D | FB | | G |  |
|
| | IP | CI | Ph | Cimifemin uno | 30 Tablet(s) | 15.01 | 27.65 | 10 % | | | Zeller Medical AG | D / SL | FB | | G |  |
L | | IP | CI | Ph | Cimifemin forte | 30 Tablet(s) | 23.40 | 43.15 | 10 % | | | Zeller Medical AG | D / SL | FB | | G |  |
| | IP | CI | Ph | Cimifemin uno | 90 Tablet(s) | 38.28 | 70.65 | 10 % | | | Zeller Medical AG | D / SL | FB | | G |  |
L | | IP | CI | Ph | Cimifemin forte | 90 Tablet(s) | 59.67 | 110.10 | 10 % | | | Zeller Medical AG | D / SL | FB | | G |  |
| | | CI | Ph | Climavita | 30 Tablet(s) | 13.87 | 25.55 | 10 % | | Coated tablets: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | Permamed AG | D / SL | FB | | G |  |
| | | CI | Ph | Climavita | 90 Tablet(s) | 35.37 | 65.25 | 10 % | | Coated tablets: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | Permamed AG | D / SL | FB | | G |  |
| | | CI | Ph | Feminelle | 30 Capsule(s) | 13.83 | 25.50 | 10 % | | Capsules: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | OM Pharma Suisse SA | D / SL | FB | | G |  |
| | | CI | Ph | Feminelle | 90 Capsule(s) | 35.26 | 65.05 | 10 % | | Capsules: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | OM Pharma Suisse SA | D / SL | FB | | G |  |
L | | IP | CI | PhCM | Climavita forte | 30 Tablet(s) | 23.40 | 43.15 | 10 % | | Tablets: Cimicifugae Extractum Ethanolicum Siccum 13 mg | Permamed AG | D / SL | FB | | G |  |
L | | IP | CI | PhCM | Climavita forte | 90 Tablet(s) | 59.67 | 110.10 | 10 % | | Tablets: Cimicifugae Extractum Ethanolicum Siccum 13 mg | Permamed AG | D / SL | FB | | G |  |
| | | | CM | Zeller Wechseljahre | 30 | PR | PR | k.A. | | | Max Zeller Söhne AG | D | FB | | G |  |
| | | | CM | Zeller Wechseljahre forte | 30 | PR | PR | k.A. | | | Max Zeller Söhne AG | D | FB | | G |  |
| | | | CM | Zeller Wechseljahre | 90 | PR | PR | k.A. | | | Max Zeller Söhne AG | D | FB | | G |  |
| | | | CM | Zeller Wechseljahre forte | 90 | PR | PR | k.A. | | | Max Zeller Söhne AG | D | FB | | G |  |
| | IP | CI | Ph | Hänseler Menopause | 30 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Hänseler AG | D | FB | | G |  |
| | IP | CI | Ph | Hänseler Menopause | 60 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Hänseler AG | D | FB | | G |  |
| | | CI | PhCM | Femicin Menopause One | 30 Capsule(s) | PR | PR | k.A. | | Capsules: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | VERFORA SA | D | FB | | G |  |
| | | CI | PhCM | Femicin Menopause One | 90 Capsule(s) | PR | PR | k.A. | | Capsules: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | VERFORA SA | D | FB | | G |  |
| | | CI | Ph | Feminelle | 60 Capsule(s) | 24.34 | 44.90 | k.A. | | Capsules: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | OM Pharma Suisse SA | D | FB | | G |  |
| | IP | CI | Ph | Cimifemin neo | 30 Tablet(s) | PR | PR | k.A. | | Tablets: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | Max Zeller Söhne AG | D | FB | | G |  |
| | IP | CI | Ph | Cimifemin neo | 90 Tablet(s) | PR | PR | k.A. | | Tablets: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | Max Zeller Söhne AG | D | FB | | G |  |
| | IP | | PhCM | Climavita neo | 30 | PR | PR | k.A. | | Tablets: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | Permamed AG | D | FB | | G |  |
| | IP | | PhCM | Climavita neo | 90 | PR | PR | k.A. | | Tablets: Cimicifugae Extractum Ethanolicum Siccum 6.5 mg | Permamed AG | D | FB | | G |  |
|
| | | CI | PhCM | MenoMed | 30 Tablet(s) | PR | PR | k.A. | | Tablets: Extractum Spissum ex Salviae Officinalis Folii Recentis Tinctura (Salvia Officinalis l., Folium) 3400 mg | A.Vogel AG | D | FB | | G |  |
| | | CI | PhCM | MenoMed | 90 Tablet(s) | PR | PR | k.A. | | Tablets: Extractum Spissum ex Salviae Officinalis Folii Recentis Tinctura (Salvia Officinalis l., Folium) 3400 mg | A.Vogel AG | D | FB | | G |  |
| | IP | | | Solcogyn | 2 x 0.5 ml | PR | PR | k.A. | | Solution: 4 Active Agents | MEDA Pharmaceuticals Switzerland GmbH | B | FB | | G |  |
|
| | | CI | H | Omida Wechseljahrbeschwerden | 12.5 g | PR | PR | k.A. | | Globules: 4 Active Agents | Omida AG | D | FB | | G |  |
| | | CI | H | Similasan Milchbildung | 4.5 g | PR | PR | k.A. | | Globules: 3 Active Agents | Similasan AG | D | FB | | G |  |
| | | CI | H | Similasan Milchbildung | 15 g | PR | PR | k.A. | | Globules: 3 Active Agents | Similasan AG | D | FB | | G |  |
| | | CI | H | Similasan Periodenbeschwerden | 15 g | PR | PR | k.A. | | Globules: 3 Active Agents | Similasan AG | D | FB | | G |  |
| | | CI | H | Similasan Wechseljahr- Beschwerden | 15 g | PR | PR | k.A. | | Globules: 3 Active Agents | Similasan AG | D | FB | | G |  |
| | | CI | H | Klimaktoplant | 100 Tablet(s) | PR | PR | k.A. | | Tablets: 2 Active Agents | Omida AG | D | FB | | G |  |
| | | CI | H | Dr. Reckeweg R 10 Klimakteran | 50 ml | PR | PR | k.A. | | Drops: 3 Active Agents | Laboratoire Jacques Reboh et fils SA | D | FB | | G |  |
| | | CI | H | Dr. Reckeweg R 28 Secalen | 50 ml | PR | PR | k.A. | | Drops: 6 Active Agents | Laboratoire Jacques Reboh et fils SA | B | FB | | G |  |
| | | CI | H | Dr. Reckeweg R 20 Euglandin-F | 50 ml | PR | PR | k.A. | | Drops: Ovarinum D12 | Laboratoire Jacques Reboh et fils SA | D | FB | | G |  |
| | | CI | H | Dr. Reckeweg R 75 Dolomensin | 50 ml | PR | PR | k.A. | | Drops: 5 Active Agents | Laboratoire Jacques Reboh et fils SA | D | FB | | G |  |
| | | CI | H | Mulimen | 100 ml | PR | PR | k.A. | | Drops: 6 Active Agents | ebi-pharm ag | D | FB | | G |  |
| | | CI | H | Sanguicimin | 50 ml | PR | PR | k.A. | | Drops: 2 Active Agents | Herbamed AG | D | FB | | G |  |
| | | CI | H | Silacten | 50 ml | PR | PR | k.A. | | Drops: 6 Active Agents | Hänseler AG | D | FB | | G |  |
| | | CI | H | Upelva | 50 ml | PR | PR | k.A. | | Drops: 8 Active Agents | ebi-pharm ag | D | FB | | G |  |
| | | CI | H | Upelva | 100 ml | PR | PR | k.A. | | Drops: 8 Active Agents | ebi-pharm ag | D | FB | | G |  |
| | | CI | | Gemmo Menopause | 30 ml | PR | PR | k.A. | | Spray zur Anwendung in der Mundhöhle: 2 Active Agents | Spagyros AG | D | FB | | G |  |
| | | | | Ustilakehl D5 | 10 suppositories | PR | PR | k.A. | | Suppositories: Ustilago Zeae D5 | ebi-pharm ag | B | FB | | G |  |
| | | | | Gynosyl | 15 ml | PR | PR | k.A. | | Drops: 5 Active Agents | Laboratoire Dr. E. Homberger SA | C | FB | | G |  |
| | | | | Gynosyl | 30 ml | PR | 10.30 | k.A. | | Drops: 5 Active Agents | Laboratoire Dr. E. Homberger SA | C | FB | | G |  |
| | | | | Gynosyl | 60 ml | PR | 18.60 | k.A. | | Drops: 5 Active Agents | Laboratoire Dr. E. Homberger SA | C | FB | | G |  |